Navigation Links
Benign eye tumors being treated

Researchers at the University of Texas feel that they may have found an effective treatment for a type of non-cancerous eye tumor that threatens clear vision.// Using photodynamic therapy, researchers successfully restored vision in three patients who were suffering from intraocular choroidal hemangiomas, which involved serious retinal detachments.

Intraocular choroidal hemangiomas are benign tumors, which can cause symptoms due to their location, growth, and the accumulation of fluid in the eye. Doctors generally don't treat the tumors unless the problems lead to vision loss or a detached retina.

In these cases, each of the patients was suffering from a tumor in one eye, and all suffered loss of vision and a detached retina. In the first case, a 60 year old man attempted reatment after experiencing decreased visual acuity in his right eye for two weeks. In the second case, a 40 year old man came to the clinic complaining of flickering lights and decreased visual acuity in his left eye. The third subject was a 65 year old man who had been initially diagnosed in 1995 and followed for the next 5 years, during which time he began to experience significantly worsening vision and an expanding central blind spot.

Researchers used photodynamic therapy to treat the detached retinas and shrink the tumors. Photodynamic therapy includes a light-sensitive dye that produces blood clots to terminate the growth of abnormal new blood vessels. In all three cases, the therapy resolved the detached retinas and shrunk the tumors beyond measurable size. Vision improved to 20/20 for the first two patients and to 20/200 for the third patient. After 10 months to 15 months of follow-up, none of the tumors had returned. Researchers conclude photodynamic therapy appears to be effective for the treatment of choroidal hemangioma.


'"/>




Page: 1

Related medicine news :

1. New Technique For Benign Breast Tumors
2. Another Treatment Option for Benign Tumors
3. ‘Benign’ MS May Not Be So Benin
4. Outpatient Treatment Kills Benign Bone Tumors Nonsurgically With Heat
5. Morphine may excite cancerous tumors
6. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
7. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
8. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
9. Same molecule found in meat, milk, tumors
10. Women with borderline ovarian tumors can still preserve their fertility
11. Surgery to remove tumors in the spine
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Benign eye tumors being treated

(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...n Thursday that plans are afoot to consider listin...g on the US bourses after 2002," Pratap C Reddy, c... it was a part of the business plan for the post-2...ot available at the moment, Dr. Reddy added that p...
...p fluid in the ears does not improve speech, heari...research. Currently there are two reasons for ear ...and liquid in the inner ear cavity of an otherwise...ned that if surgery is not used in the second case...
...embers to refrain from conducting sex-determinatio...ould be extended to practitioners caught in the ac...should warn our members against aiding in such hei...int secretary, IMA headquarters, New Delhi. He was...
...l School in Durham, North Carolina and colleagues ...al of pain. Patients who use religion or spiritual...thritis can reduce their pain and boost their sens.... Francis says, "One might expect that people copi...
Other Medicine News:Health News:Researchers urge caution in using ear tube surgery 2Health News:Researchers urge caution in using ear tube surgery 3
(Date:10/9/2008)...ed Sales and Marketing Efforts to Accelerate ... MENLO PARK, Calif., Oct. 9 /- Evalv...for the percutaneous repair of cardiac valves,has...ith the appointment of,Sean Cleary as senior vice ...is Richardson, as vice president of sales., "The ...
(Date:10/9/2008)...wswire-FirstCall/ -- Diamyd Medical reports,that t...ew England Journal,of Medicine, has published an a...e Diamyd(R) diabetes vaccine for type 1 diabetes.,...0314/297194 ), The article is now available on t...will be in print on October 30. It presents the,re...
(Date:10/8/2008)...orm Treatments for Spinal Cord, Other Nerve,Injuri.../ -- A protein that enables,nerve cells to communi...ng,the developing nervous system. Research into ho...mong nerve cells may provide a basis for eventual,...ir nervous system,including spinal cord injury., ...
(Date:10/8/2008)...Scientists Expand Testing Using Cellular ..., Maine, Oct. 8 /- Wild Blueberry ant...of results from a new study,showing Wild Blueberri...uits like apples, bananas, red grapes and strawber...idant Activity (CAA) assay. New research,published...
Breaking Medicine Technology:Evalve Expands Executive Leadership Team 2Evalve Expands Executive Leadership Team 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Controversial shoulder surgery for first time dislocation proven effective long term 13827 1Controversial shoulder surgery for first time dislocation proven effective long term 13827 2Controversial Shoulder Surgery for First time Dislocation Proven Effective Long Term 1483 1Controversial Shoulder Surgery for First time Dislocation Proven Effective Long Term 1483 2Controversial Shoulder Surgery for First time Dislocation Proven Effective Long Term 1483 3Purdue leads center to simulate behavior of micro electromechanical systems 3802 1Purdue leads center to simulate behavior of micro electromechanical systems 3802 2Purdue leads center to simulate behavior of micro electromechanical systems 3802 3Purdue leads center to simulate behavior of micro electromechanical systems 3802 4Keryx Biopharmaceuticals Announces that the SUN MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint 1482 1Keryx Biopharmaceuticals Announces that the SUN MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint 1482 2Keryx Biopharmaceuticals Announces that the SUN MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint 1482 3Keryx Biopharmaceuticals Announces that the SUN MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint 1482 4
..., March 06, 2007 /PRNewswire/ -- Up to two million...to 600,000,hospitalized. Its primary complication,...es annually -- more than breast cancer and,AIDS co...ase may be,at increased risk for DVT, because thes...ots and pooling. Respiratory tract infection,may i...
...stria and CHAPEL HILL, N.C., US, March 06, 2007,/P...Orphan") and,Lantibio, Inc. ("Lantibio") today ann...ontrolled, double-blinded Phase II clinical,study ...tic,fibrosis ("CF"). Moli1901 is being developed b...rcialization agreement with,Lantibio. The study, p...
Other Medicine Technology:DVT Awareness Survey Findings: Heart and Respiratory Patients 2AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 2AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 3AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 4
Shielding's Fast Wrap Apron offers both comfort and ease of wearing. Adjustable back shoulder strap keeps apron snug. No ties or buckles.
Shielding's new Breast Overlay Apron is exclusively designed to provide extra coverage for this vulnerable area. The adjustable velcro flaps allow for a quick, comfortable fit, plust added coverage f
Upper arm protection
Collars can be attach to any Pulse aprons.
Medicine Products: